The U.S. Food and Drug Administration (FDA) has announced a new warning labeling change regarding bevacizumab (Avastin) a cancer drug currently in use to treat colorectal cancer, that state an increased risk for a brain-bleeding condition and potential nasal septum perforation that can create a hole in the nose for those patients being treated with Avastin. The rare brain-capillary leak can trigger headache, seizure, blindness and other vision and neurological problems.The FDA has published a letter sent by Genentec to healthcare providers notifying them of the new warnings, available as a pdf document.
In the meantime, Avastin's drug maker Genentech has asked for FDA approval for the drug in the treatment of advanced lung cancer and breast cancer.


Maybe I have been weaving my way through the web for too many years that shades my perspective cynical and jaded but there are few internet destinations I trust outright. Certainly not when it comes to purchasing drugs. Questions of purity, reliability of ingredients and quality immediately come to mind. Equally at issue is the folly of self diagnosis and self prescribing medications for self described illness or malady.
The Northwest Arkansas Morning News is featuring a story about Nicole Young, and her new non-profit Message In A Bottle project, that is providing inspiration to cancer patients and their families with hand-written messages delivered in a bottle.
Traditionally, the medical community has focused its resources on cancer treatment in saving lives. Rather recently, there is a growing trend and interest in cancer prevention. As a result, there is more awareness and conversation about the causes of cancer, and the ways to prevent cancer. Although less than ten percent of the population links cancer risks to obesity, one of the leading lifestyle factors that is known to raise the risk for cancer is obesity. The Rudd Center for Food Policy and Obesity at Yale University conducted an 







